{{badgeTamara}} Split in {{numberOfInstallments}} interest-free payments of {{repaymentAmount}}
Trusted & Free Shipping
100% Secure Payment
Genuine Brands
Overview
Dispensing Mode: Prescription only medication
Active Ingredient: Omega-3-acid ethyl esters (highly purified fish oil fatty acids EPA and DHA) 1000 mg per softgel
Primary Use: Treatment of hypertriglyceridaemia (high blood triglycerides) when diet changes alone are insufficient
Benefits
Used in the treatment of hypertriglyceridaemia (high triglycerides) by lowering triglyceride levels in the blood when diet and exercise alone are insufficient
Used to support heart and cardiovascular health as part of a comprehensive care plan under medical supervision
Helps reduce very low-density lipoprotein (VLDL) production and triglyceride synthesis in the liver
Provides prescription-strength omega-3 fatty acids (EPA and DHA) with consistent, pharmaceutical-grade potency compared to general fish oil supplements
How to Use
Disclaimer: This product is a prescription-only medicine and must be used strictly under the supervision of a licensed healthcare professional. Always adhere to the directions provided on the prescription label. Consult your doctor if you have any questions or concerns regarding its use.
Description
Omacor Omega-3 1000 mg Softgels are a prescription-strength omega-3 fatty acid medicine that delivers concentrated omega-3-acid ethyl esters, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in a purified softgel form. These essential long-chain polyunsaturated fatty acids are derived from fish oil and cannot be produced by the body, so pharmaceutical-grade formulations like Omacor are used when therapeutic intervention is needed. This medicine is indicated for the reduction of high triglyceride levels (hypertriglyceridaemia) as an adjunct to diet, lifestyle modifications, and other prescribed therapies when triglycerides remain elevated despite initial measures. EPA and DHA help lower VLDL production and hepatic triglyceride synthesis, contributing to a decrease in circulating triglyceride levels a key factor in managing cardiovascular risk. Omacor is often included as part of an overall cardiovascular health plan, particularly for adults with elevated blood fats where reduction of triglycerides is a clinical goal. In some treatment plans, it may also be used in certain post-heart attack care strategies or when a targeted anti-lipid intervention is clinically appropriate. Use should be guided by a healthcare professional, with regular monitoring of lipid levels and overall health status during treatment.